Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial

Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial

Abstract Coronavirus disease 2019 (COVID‐19) is associated with endothelial dysfunction. Pharmacologically targeting the different mechanisms of endothelial dysfunction may improve clinical outcomes and lead to reduced morbidity and mortality. In this pilot, double‐blind, placebo‐controlled, randomi...

Full description

Bibliographic Details
Main Authors: Kamal Matli, Abdulrahman Al Kotob, Wassim Jamaleddine, Soad Al Osta, Pascale Salameh, Rami Tabbikha, Nibal Chamoun, Ahmad Moussawi, Jean‐Michel Saad, Gibran Atwi, Tarik Abu Saad, Omar Jamal, Jacques Mokhbat, Georges Ghanem
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13369

Internet

https://doi.org/10.1111/cts.13369

Similar Items